$TWST
Twist Bioscience Corp

2019 Q2 Form 10-Q Financial Statement

#000119312519133596 Filed on May 02, 2019

View on sec.gov

Income Statement

Concept 2019 Q2 2019 Q1 2018 Q4
Revenue $13.60M $13.56M $11.49M
YoY Change 107.92% 119.87% 166.45%
Cost Of Revenue $11.39M $11.79M $11.86M
YoY Change 51.86% 45.63% 58.14%
Gross Profit $2.206M $1.768M -$365.0K
YoY Change -329.31% -191.65% -88.54%
Gross Profit Margin 16.22% 13.04% -3.18%
Selling, General & Admin $21.32M $19.12M $15.26M
YoY Change 89.41% 91.66% 64.73%
% of Gross Profit 966.46% 1081.67%
Research & Development $9.007M $8.907M $7.273M
YoY Change 70.98% 89.07% 69.02%
% of Gross Profit 408.3% 503.79%
Depreciation & Amortization $1.580M $1.570M $1.472M
YoY Change -7.06% 11.35% 14.46%
% of Gross Profit 71.62% 88.8%
Operating Expenses $30.33M $28.03M $34.39M
YoY Change 83.53% 90.83% 63.26%
Operating Profit -$28.12M -$26.26M -$22.90M
YoY Change 60.82% 58.04% 36.69%
Interest Expense $318.0K $340.0K $348.0K
YoY Change -5.64% 7.26% 27.47%
% of Operating Profit
Other Income/Expense, Net -$227.0K -$21.00K -$15.00K
YoY Change 1521.43% -51.16% -21.05%
Pretax Income -$27.86M -$25.85M -$22.60M
YoY Change 58.73% 53.59% 33.82%
Income Tax $54.00K $84.00K $43.00K
% Of Pretax Income
Net Earnings -$27.92M -$25.93M -$22.64M
YoY Change 58.4% 53.7% 33.67%
Net Earnings / Revenue -205.26% -191.29% -197.0%
Basic Earnings Per Share
Diluted Earnings Per Share -$921.8K -$929.7K -$1.180M
COMMON SHARES
Basic Shares Outstanding 28.04M shares 28.02M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2019 Q2 2019 Q1 2018 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $161.8M $104.3M $130.2M
YoY Change 74.92%
Cash & Equivalents $68.21M $28.69M $66.46M
Short-Term Investments $93.60M $75.60M $63.70M
Other Short-Term Assets $3.600M $4.200M $4.000M
YoY Change 33.33%
Inventory $5.496M $4.449M $5.561M
Prepaid Expenses
Receivables $11.70M $7.998M $6.978M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $182.6M $121.0M $146.7M
YoY Change 75.94%
LONG-TERM ASSETS
Property, Plant & Equipment $19.82M $14.94M $13.60M
YoY Change 54.82%
Goodwill $1.138M $1.138M $1.138M
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $2.090M $1.912M $1.816M
YoY Change -50.24%
Total Long-Term Assets $24.18M $19.18M $17.79M
YoY Change 27.95%
TOTAL ASSETS
Total Short-Term Assets $182.6M $121.0M $146.7M
Total Long-Term Assets $24.18M $19.18M $17.79M
Total Assets $206.8M $140.2M $164.5M
YoY Change 68.55%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $7.835M $4.505M $6.725M
YoY Change 74.11%
Accrued Expenses $3.713M $2.412M $2.606M
YoY Change -38.12%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $3.333M $3.333M $3.333M
YoY Change 96.06%
Total Short-Term Liabilities $25.45M $18.58M $19.00M
YoY Change 40.59%
LONG-TERM LIABILITIES
Long-Term Debt $5.119M $5.828M $6.526M
YoY Change -98.22%
Other Long-Term Liabilities $236.0K $282.0K $333.0K
YoY Change -21.33%
Total Long-Term Liabilities $5.355M $6.110M $6.859M
YoY Change -98.14%
TOTAL LIABILITIES
Total Short-Term Liabilities $25.45M $18.58M $19.00M
Total Long-Term Liabilities $5.355M $6.110M $6.859M
Total Liabilities $30.80M $24.69M $25.86M
YoY Change -89.91%
SHAREHOLDERS EQUITY
Retained Earnings -$287.3M -$259.4M -$233.5M
YoY Change
Common Stock $0.00 $0.00 $0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $176.0M $115.5M $138.6M
YoY Change
Total Liabilities & Shareholders Equity $206.8M $140.2M $164.5M
YoY Change 68.55%

Cashflow Statement

Concept 2019 Q2 2019 Q1 2018 Q4
OPERATING ACTIVITIES
Net Income -$27.92M -$25.93M -$22.64M
YoY Change 58.4% 53.7% 33.67%
Depreciation, Depletion And Amortization $1.580M $1.570M $1.472M
YoY Change -7.06% 11.35% 14.46%
Cash From Operating Activities -$22.08M -$20.82M -$21.68M
YoY Change 30.34% 26.11% 35.39%
INVESTING ACTIVITIES
Capital Expenditures -$5.170M -$3.770M $1.922M
YoY Change 720.63% 654.0% 27.2%
Acquisitions
YoY Change
Other Investing Activities -$17.53M -$11.39M -$63.84M
YoY Change -436.47% -178.01% -756.12%
Cash From Investing Activities -$22.70M -$15.16M -$65.76M
YoY Change -595.63% -207.52% -900.45%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $84.30M $69.60M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 84.28M -1.630M 73.00M
YoY Change 239.43% -102.98% 2642.26%
NET CHANGE
Cash From Operating Activities -22.08M -20.82M -21.68M
Cash From Investing Activities -22.70M -15.16M -65.76M
Cash From Financing Activities 84.28M -1.630M 73.00M
Net Change In Cash 39.50M -37.61M -14.44M
YoY Change 216.76% -171.86% 181.03%
FREE CASH FLOW
Cash From Operating Activities -$22.08M -$20.82M -$21.68M
Capital Expenditures -$5.170M -$3.770M $1.922M
Free Cash Flow -$16.91M -$17.05M -$23.61M
YoY Change 3.68% 6.5% 34.68%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
28039937 shares
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
-149703000
CY2018Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
78634000
CY2018Q1 us-gaap Stockholders Equity
StockholdersEquity
-165721000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
138596000
CY2019Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2412000
CY2019Q1 us-gaap Assets Current
AssetsCurrent
120991000
CY2019Q1 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
104324000
CY2019Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
7998000
CY2019Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
375043000
CY2019Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
4505000
CY2019Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-136000
CY2019Q1 us-gaap Assets
Assets
140170000
CY2019Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
28693000
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
29488000
CY2019Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2019Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
28024052 shares
CY2019Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2019Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
28024052 shares
CY2019Q1 us-gaap Common Stock Value
CommonStockValue
0
CY2019Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
35000000
CY2019Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
7436000
CY2019Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
630000
CY2019Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1240000
CY2019Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
610000
CY2019Q1 us-gaap Goodwill
Goodwill
1138000
CY2019Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
3508000
CY2019Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
425000
CY2019Q1 us-gaap Inventory Net
InventoryNet
4449000
CY2019Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
516000
CY2019Q1 us-gaap Liabilities Current
LiabilitiesCurrent
18580000
CY2019Q1 us-gaap Liabilities
Liabilities
24690000
CY2019Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
140170000
CY2019Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
3333000
CY2019Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
5828000
CY2019Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1912000
CY2019Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2019Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
894000
CY2019Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
282000
CY2019Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
14940000
CY2019Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2019Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2019Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2019Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4220000
CY2019Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2019Q1 us-gaap Restricted Cash Current
RestrictedCashCurrent
216000
CY2019Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-259427000
CY2019Q1 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
579000
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
3932469 shares
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
14.58
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3932469 shares
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
14.58
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
37088000
CY2019Q1 us-gaap Short Term Investments
ShortTermInvestments
75631000
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
37088000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
115480000
CY2019Q1 twst Share Based Compensation Arrangement By Share Based Payment Award Options Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAvailableForGrant
1397566 shares
CY2017Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
31429000
CY2017Q3 us-gaap Stockholders Equity
StockholdersEquity
-133358000
CY2018Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2166000
CY2018Q3 us-gaap Assets Current
AssetsCurrent
95671000
CY2018Q3 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
80757000
CY2018Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5419000
CY2018Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
9346000
CY2018Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
7531000
CY2018Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
87000
CY2018Q3 us-gaap Assets
Assets
115791000
CY2018Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
80757000
CY2018Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
81537000
CY2018Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
27775000 shares
CY2018Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3206048 shares
CY2018Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2018Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3206048 shares
CY2018Q3 us-gaap Common Stock Value
CommonStockValue
0
CY2018Q3 us-gaap Deferred Costs
DeferredCosts
3700000
CY2018Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
5401000
CY2018Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
528000
CY2018Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1240000
CY2018Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
712000
CY2018Q3 us-gaap Goodwill
Goodwill
1138000
CY2018Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
2988000
CY2018Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
767000
CY2018Q3 us-gaap Inventory Net
InventoryNet
6028000
CY2018Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
2273000
CY2018Q3 us-gaap Liabilities Current
LiabilitiesCurrent
18537000
CY2018Q3 us-gaap Liabilities
Liabilities
26730000
CY2018Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
115791000
CY2018Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
2500000
CY2018Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
7218000
CY2018Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
5360000
CY2018Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2018Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
939000
CY2018Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
344000
CY2018Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12331000
CY2018Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2018Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
0 shares
CY2018Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2018Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3467000
CY2018Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2018Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
201000
CY2018Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-210855000
CY2018Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
579000
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2520485 shares
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
8.22
CY2018Q3 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
290483000
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
11483000
CY2018Q3 us-gaap Stockholders Equity
StockholdersEquity
-201422000
CY2018Q3 twst Convertible Preferred Stock Warrant Liability
ConvertiblePreferredStockWarrantLiability
631000
CY2018Q3 twst Share Based Compensation Arrangement By Share Based Payment Award Options Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAvailableForGrant
860287 shares
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1272000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
20052786 shares
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
153000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1272000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
47205000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-33789000
us-gaap Cost Of Revenue
CostOfRevenue
15593000
us-gaap Costs And Expenses
CostsAndExpenses
43848000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2701000
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-12.74
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
46000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-36000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-33715000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
95000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1307000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
492000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
12000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
259000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1670000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
70000
us-gaap Interest Expense
InterestExpense
590000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-433000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1287000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-247000
us-gaap Interest Paid Net
InterestPaidNet
390000
us-gaap Investment Income Interest
InvestmentIncomeInterest
306000
us-gaap Liabilities Assumed1
LiabilitiesAssumed1
24000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
22322000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
57409000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-32526000
us-gaap Net Income Loss
NetIncomeLoss
-33810000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
21000
us-gaap Other Noncash Expense
OtherNoncashExpense
87000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-62000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
21000
us-gaap Noncash Or Part Noncash Acquisition Payables Assumed1
NoncashOrPartNoncashAcquisitionPayablesAssumed1
40000
us-gaap Operating Income Loss
OperatingIncomeLoss
-33369000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
3374000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2012000
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
1835000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
282000
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
27700000
dei Entity Central Index Key
EntityCentralIndexKey
0001581280
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P3Y10M24D
dei Entity Registrant Name
EntityRegistrantName
Twist Bioscience Corp
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
8000
us-gaap Proceeds From Issuance Of Redeemable Convertible Preferred Stock
ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock
58962000
us-gaap Related Party Transaction Purchases From Related Party
RelatedPartyTransactionPurchasesFromRelatedParty
1100000
us-gaap Profit Loss
ProfitLoss
-33810000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9014000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
10479000
us-gaap Share Based Compensation
ShareBasedCompensation
1272000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
154000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
19241000
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
0
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
2653805000 shares
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4775000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4610815 shares
dei Amendment Flag
AmendmentFlag
false
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
152000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4775000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
521000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-52049000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-48795000
us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
290462000
us-gaap Cost Of Revenue
CostOfRevenue
23646000
us-gaap Costs And Expenses
CostsAndExpenses
74209000
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--09-30
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3035000
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2019
dei Document Type
DocumentType
10-Q
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.06
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
127000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2017000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
731000
dei Entity Small Business
EntitySmallBusiness
true
dei Document Period End Date
DocumentPeriodEndDate
2019-03-31
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
true
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
us-gaap Goodwill Period Increase Decrease
GoodwillPeriodIncreaseDecrease
0
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-8000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-48445000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
161000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
191000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2579000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
658000
us-gaap Interest Expense
InterestExpense
688000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
2035000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1579000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-253000
us-gaap Interest Paid Net
InterestPaidNet
413000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
245000
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
11400000
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
71953000
us-gaap Investment Income Interest
InvestmentIncomeInterest
1439000
us-gaap Liabilities Assumed1
LiabilitiesAssumed1
186000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-80917000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
71365000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-42497000
us-gaap Net Income Loss
NetIncomeLoss
-48572000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-223000
us-gaap Other Noncash Expense
OtherNoncashExpense
125000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-36000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-236000
us-gaap Noncash Or Part Noncash Acquisition Payables Assumed1
NoncashOrPartNoncashAcquisitionPayablesAssumed1
20000
us-gaap Operating Income Loss
OperatingIncomeLoss
-49160000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
13000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
86625000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5692000
us-gaap Related Party Transaction Description Of Transaction
RelatedPartyTransactionDescriptionOfTransaction
During the three months ended March 31, 2018 and 2019, the Company purchased raw materials from a related party investor in the amount of $0.7 million and $0.9 million, respectively. During the six months ended March 31, 2018 and 2019, the Company purchased raw materials from a related party investor in the amount of $1.1 million and $2.1 million, respectively. Payable balances and cash receipts and receivable balances with the related party were immaterial as of September 30, 2018 and March 31, 2019.
us-gaap Related Party Transaction Purchases From Related Party
RelatedPartyTransactionPurchasesFromRelatedParty
2100000
us-gaap Profit Loss
ProfitLoss
-48572000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
16180000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
833000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
25049000
us-gaap Share Based Compensation
ShareBasedCompensation
4775000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P9Y6M25D
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
4.13
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
69597000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
232000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
34383000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P9Y6M25D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
39839 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1511842 shares
dei Trading Symbol
TradingSymbol
TWST
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
24.67
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
12.04
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
0
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
60019 shares
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
290462000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
23539617000 shares
twst Deferred Offering Costs Incurred
DeferredOfferingCostsIncurred
1600000
twst Conversion Of Convertible Preferred Stock Warrant
ConversionOfConvertiblePreferredStockWarrant
631000
twst Stock Issued During Period Value Conversion Of Convertible Warrant
StockIssuedDuringPeriodValueConversionOfConvertibleWarrant
631000
twst Underwriting Discounts Commissions And Offering Expenses
UnderwritingDiscountsCommissionsAndOfferingExpenses
10903000
twst Share Based Compensation Arrangement By Share Based Payment Award Number Of Options Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfOptionsAvailableForGrant
1511842 shares
twst Share Based Compensation Arrangement By Share Based Payment Award Options Available For Grant Forfeited
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAvailableForGrantForfeited
39839 shares
twst Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant Restricted Stock Units Forfeited
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantRestrictedStockUnitsForfeited
220 shares
twst Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant Options Repurchased
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantOptionsRepurchased
442 shares
twst Share Based Compensation Arrangement By Share Based Payment Award Options Available For Grant Additional Shares Authorized In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAvailableForGrantAdditionalSharesAuthorizedInPeriod
2494700 shares
twst Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant Restricted Stock Units Granted In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantRestrictedStockUnitsGrantedInPeriod
486080 shares
twst Stock Issued During Period Shares Conversion Of Convertible Warrant
StockIssuedDuringPeriodSharesConversionOfConvertibleWarrant
0 shares
CY2018Q4 twst Net Exercise Of Common Stock Warrants Shares
NetExerciseOfCommonStockWarrantsShares
68901 shares
CY2018Q4 twst Common Stock Issued For Cashless Exercise
CommonStockIssuedForCashlessExercise
57122 shares
CY2018Q4 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
69600000
CY2018Q4 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
One-for-0.101
CY2018Q4 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.101 pure
CY2018 us-gaap Goodwill Period Increase Decrease
GoodwillPeriodIncreaseDecrease
0
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y4M17D
CY2018Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
736000
CY2018Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
736000
CY2018Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-16861000
CY2018Q1 us-gaap Cost Of Revenue
CostOfRevenue
8095000
CY2018Q1 us-gaap Costs And Expenses
CostsAndExpenses
22784000
CY2018Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-6.32
CY2018Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-16830000
CY2018Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
43000
CY2018Q1 us-gaap Interest Expense
InterestExpense
317000
CY2018Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
148000
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
-16873000
CY2018Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
12000
CY2018Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-43000
CY2018Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
11000
CY2018Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-16618000
CY2018Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
1000
CY2018Q1 us-gaap Related Party Transaction Purchases From Related Party
RelatedPartyTransactionPurchasesFromRelatedParty
700000
CY2018Q1 us-gaap Profit Loss
ProfitLoss
-16873000
CY2018Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4711000
CY2018Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
6166000
CY2018Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
107000
CY2018Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
9978000
CY2018Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
0
CY2018Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
2669541000 shares
CY2019Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2911000
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2911000
CY2019Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-26093000
CY2019Q1 us-gaap Cost Of Revenue
CostOfRevenue
11789000
CY2019Q1 us-gaap Costs And Expenses
CostsAndExpenses
39820000
CY2019Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.93
CY2019Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-25849000
CY2019Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
84000
CY2019Q1 us-gaap Interest Expense
InterestExpense
340000
CY2019Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
775000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-25933000
CY2019Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-160000
CY2019Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-21000
CY2019Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-180000
CY2019Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-26263000
CY2019Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
20000
CY2019Q1 us-gaap Related Party Transaction Purchases From Related Party
RelatedPartyTransactionPurchasesFromRelatedParty
900000
CY2019Q1 us-gaap Profit Loss
ProfitLoss
-25933000
CY2019Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8907000
CY2019Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
13557000
CY2019Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
66000
CY2019Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
19124000
CY2019Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
27891700000 shares

Files In Submission

Name View Source Status
0001193125-19-133596-index-headers.html Edgar Link pending
0001193125-19-133596-index.html Edgar Link pending
0001193125-19-133596.txt Edgar Link pending
0001193125-19-133596-xbrl.zip Edgar Link pending
d712201d10q.htm Edgar Link pending
d712201dex101.htm Edgar Link pending
d712201dex102.htm Edgar Link pending
d712201dex311.htm Edgar Link pending
d712201dex312.htm Edgar Link pending
d712201dex321.htm Edgar Link pending
d712201dex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
g712201dsp05aa.jpg Edgar Link pending
g712201dsp05b.jpg Edgar Link pending
g712201dsp5.jpg Edgar Link pending
g712201page010.jpg Edgar Link pending
g712201ppageformat.jpg Edgar Link pending
g712201snap0001_12.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
twst-20190331.xml Edgar Link completed
twst-20190331.xsd Edgar Link pending
twst-20190331_cal.xml Edgar Link unprocessable
twst-20190331_def.xml Edgar Link unprocessable
twst-20190331_lab.xml Edgar Link unprocessable
twst-20190331_pre.xml Edgar Link unprocessable